Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin) Therapy in the Inpatients With Type 2 Diabetes

NCT01378117 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Hospitalization
Hyperglycemia

Interventions

DRUG: Sitagliptin
DRUG: glargine
DRUG: lispro

Sponsor

Emory University

Collaborators

[object Object]